HER2-positive breast cancer
In HER2-positive breast cancer, HER2 stimulates downstream signaling pathways such as RAS-RAF-ERK and PI3K-PTEN-AKT, promoting cancer cell proliferation. As a result, HER2 has become a crucial biomarker for cancer diagnosis and a major therapeutic target in treatments such as antibody-drug conjugates (ADCs).